JPMorgan Chase & Co (JPM)vsTexas Capital Bancshares Inc (TCBIO)
JPM
JPMorgan Chase & Co
$313.23
-0.25%
FINANCIAL SERVICES · Cap: $828.64B
TCBIO
Texas Capital Bancshares Inc
$21.58
-0.35%
FINANCIAL SERVICES · Cap: $3.31B
Smart Verdict
WallStSmart Research — data-driven comparison
JPMorgan Chase & Co generates 13837% more annual revenue ($173.56B vs $1.25B). JPM leads profitability with a 33.9% profit margin vs 28.7%. TCBIO trades at a lower P/E of 5.5x. JPM earns a higher WallStSmart Score of 73/100 (B).
JPM
Strong Buy73
out of 100
Grade: B
TCBIO
Buy54
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Keeps 34 of every $100 in revenue as profit
Strong operational efficiency at 43.0%
Generating 368.4B in free cash flow
Attractively priced relative to earnings
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 32.2%
Earnings expanding 69.6% YoY
Keeps 29 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Elevated debt levels
Distress zone — elevated risk
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : JPM
The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 33.9% and operating margin at 43.0%. Revenue growth of 12.7% demonstrates continued momentum.
Bull Case : TCBIO
The strongest argument for TCBIO centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 28.7% and operating margin at 32.2%. Revenue growth of 16.9% demonstrates continued momentum.
Bear Case : JPM
The primary concerns for JPM are PEG Ratio, Debt/Equity, Altman Z-Score.
Bear Case : TCBIO
The primary concerns for TCBIO are Altman Z-Score.
Key Dynamics to Monitor
JPM profiles as a mature stock while TCBIO is a growth play — different risk/reward profiles.
JPM carries more volatility with a beta of 1.04 — expect wider price swings.
TCBIO is growing revenue faster at 16.9% — sustainability is the question.
JPM generates stronger free cash flow (368.4B), providing more financial flexibility.
Bottom Line
JPM scores higher overall (73/100 vs 54/100), backed by strong 33.9% margins and 12.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
JPMorgan Chase & Co
FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA
JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.
Visit Website →Texas Capital Bancshares Inc
FINANCIAL SERVICES · BANKS - REGIONAL · USA
Texas Capital Bancshares Inc (TCBIO), headquartered in Dallas, Texas, is a leading regional bank offering a comprehensive suite of financial services that cater to both commercial and individual clients. The firm excels in providing customized solutions including business lending, treasury management, and personal banking, driven by a strong emphasis on client relationships and in-depth local market insights. With a robust approach to risk management and a strategic focus on sustainable growth, TCBIO is strategically positioned to thrive in a competitive environment while delivering long-term value for its shareholders.
Compare with Other BANKS - DIVERSIFIED Stocks
Want to dig deeper into these stocks?